A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160

Name: A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
License: Public Domain

National Institute of Allergy and Infectious Diseases (NIAID)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hiv infections

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 407779
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.